Robert F. Witter

1.4k total citations
42 papers, 969 citations indexed

About

Robert F. Witter is a scholar working on Molecular Biology, Pharmacology and Clinical Biochemistry. According to data from OpenAlex, Robert F. Witter has authored 42 papers receiving a total of 969 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 5 papers in Pharmacology and 5 papers in Clinical Biochemistry. Recurrent topics in Robert F. Witter's work include Mitochondrial Function and Pathology (9 papers), Enzyme function and inhibition (6 papers) and Metabolism and Genetic Disorders (5 papers). Robert F. Witter is often cited by papers focused on Mitochondrial Function and Pathology (9 papers), Enzyme function and inhibition (6 papers) and Metabolism and Genetic Disorders (5 papers). Robert F. Witter collaborates with scholars based in United States. Robert F. Witter's co-authors include Mary A. Cottone, Elmer Stotz, Kenneth J. Monty, Alexander L. Dounce, M. Kuchmak, G.V. Marinetti, Michael L. Watson, Thomas B. Gaines, Anne L. Morrison and George Rouser and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and The Journal of Experimental Medicine.

In The Last Decade

Robert F. Witter

42 papers receiving 839 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert F. Witter United States 17 497 128 127 101 101 42 969
Lewis C. Mokrasch United States 15 681 1.4× 102 0.8× 171 1.3× 90 0.9× 58 0.6× 42 1.3k
G. A. Levvy United Kingdom 22 1.1k 2.2× 219 1.7× 184 1.4× 75 0.7× 127 1.3× 29 1.9k
H. Wagner Germany 21 623 1.3× 248 1.9× 59 0.5× 52 0.5× 152 1.5× 101 1.5k
E.F. Phares United States 14 536 1.1× 50 0.4× 61 0.5× 79 0.8× 47 0.5× 22 897
Edward J. Barron United States 13 476 1.0× 73 0.6× 105 0.8× 98 1.0× 47 0.5× 19 911
L.S. Yengoyan United States 11 580 1.2× 65 0.5× 74 0.6× 72 0.7× 81 0.8× 13 877
Vasudev C. Joshi United States 6 573 1.2× 59 0.5× 147 1.2× 65 0.6× 53 0.5× 9 913
Robert N. Feinstein United States 17 420 0.8× 51 0.4× 152 1.2× 65 0.6× 39 0.4× 61 868
F. Dickens United Kingdom 18 471 0.9× 363 2.8× 107 0.8× 96 1.0× 43 0.4× 36 1.2k
Hanns Schmitz Germany 7 668 1.3× 59 0.5× 89 0.7× 100 1.0× 25 0.2× 15 1.1k

Countries citing papers authored by Robert F. Witter

Since Specialization
Citations

This map shows the geographic impact of Robert F. Witter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert F. Witter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert F. Witter more than expected).

Fields of papers citing papers by Robert F. Witter

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert F. Witter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert F. Witter. The network helps show where Robert F. Witter may publish in the future.

Co-authorship network of co-authors of Robert F. Witter

This figure shows the co-authorship network connecting the top 25 collaborators of Robert F. Witter. A scholar is included among the top collaborators of Robert F. Witter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert F. Witter. Robert F. Witter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Witter, Robert F., et al.. (1970). Lipids of Commercial Serum Products Offered as Controls or "Standards" for Cholesterol and Triglyceride Determinations. Clinical Chemistry. 16(9). 743–748. 8 indexed citations
2.
Kuchmak, M., et al.. (1969). Quantitative determination of phospholipid classes in human serum by combined thin-layer chromatography and phosphorus analysis. Clinica Chimica Acta. 25(3). 447–452. 10 indexed citations
3.
Kuchmak, M., et al.. (1966). Phospholipids of human serum. Lipids. 1(2). 89–97. 47 indexed citations
4.
Witter, Robert F., et al.. (1966). A simplified version of the michel method for plasma or red cell cholinesterase. Clinica Chimica Acta. 13(1). 76–78. 7 indexed citations
5.
Cooper, Gerald R., et al.. (1966). Variables in the technicon‐N‐24 method for the determination of serum cholesterol. Journal of the American Oil Chemists Society. 43(12). 649–651. 1 indexed citations
6.
Witter, Robert F., et al.. (1966). Experience with commercially prepared reagents for the determination of serum glutamic oxalacetic transaminase by the method of Karmen. Clinica Chimica Acta. 13(4). 512–514. 1 indexed citations
7.
Witter, Robert F.. (1963). Measurement of Blood Cholinesterase. Archives of Environmental Health An International Journal. 6(4). 537–563. 68 indexed citations
8.
Witter, Robert F. & Thomas B. Gaines. (1963). Rate of formationin vivo of the unreactivatable form of brain cholinesterase in chickens given DDVP or malathion. Biochemical Pharmacology. 12(12). 1421–1427. 15 indexed citations
9.
Witter, Robert F.. (1962). A critical study of the manometric assay of cholinesterase in rat blood. Toxicology and Applied Pharmacology. 4(3). 313–323. 15 indexed citations
10.
Marinetti, G.V., et al.. (1958). STUDIES OF THE HEMOLYSIS OF RED BLOOD CELLS BY MUMPS VIRUS. The Journal of Experimental Medicine. 107(1). 87–94. 9 indexed citations
11.
Witter, Robert F., et al.. (1958). Circular Chromatography of Phospholipides. Analytical Chemistry. 30(10). 1624–1625. 5 indexed citations
12.
Marinetti, G.V., et al.. (1958). Metabolic pathways of lysolecithn in a soluble rat-liver system. Biochimica et Biophysica Acta. 30(1). 223–223. 26 indexed citations
13.
Witter, Robert F., et al.. (1958). Effect of Synthetic Detergents on the Swelling and the ATPase of Mitochondria Isolated from Rat Liver. The Journal of Cell Biology. 4(1). 73–82. 17 indexed citations
14.
Witter, Robert F., et al.. (1957). Paper chromatography of phospholipides with solvent mixtures of ketones and acetic acid. Archives of Biochemistry and Biophysics. 68(1). 15–20. 20 indexed citations
15.
Witter, Robert F., et al.. (1957). Spot Test for 3-Hydroxy Delta−5 Steroids. Analytical Chemistry. 29(1). 156–157. 16 indexed citations
16.
Witter, Robert F., Michael L. Watson, & Mary A. Cottone. (1955). MORPHOLOGY AND ATP-ASE OF ISOLATED MITOCHONDRIA. The Journal of Cell Biology. 1(2). 127–138. 78 indexed citations
17.
Witter, Robert F., Mary A. Cottone, & Elmer Stotz. (1954). FORMATION OF ACETOACETATE FROM FATTY ACIDS BY PARTICULATE SYSTEMS OF RAT LIVER. Journal of Biological Chemistry. 207(2). 671–678. 9 indexed citations
18.
Witter, Robert F., et al.. (1953). STUDIES OF THE MECHANISM OF ACTION OF DINITROPHENOL. Journal of Biological Chemistry. 202(1). 291–303. 21 indexed citations
19.
Witter, Robert F., Walter J. Pories, & Mary A. Cottone. (1953). Large Scale Preparation of Liver Mitochondria with the Waring Blendor.. Experimental Biology and Medicine. 84(3). 674–677. 3 indexed citations
20.
Witter, Robert F., et al.. (1952). INFLUENCE OF ORTHOPHOSPHATE ON THE OXIDATION OF HEXANOATE AND ITS DERIVATIVES IN VITRO. Journal of Biological Chemistry. 195(2). 663–668. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026